Y-mAbs Therapeutics, Inc. ( YMAB) - Stock Earnings
Stock symbol YMAB is outdated, potentially delisted? Maybe it is available on other exchange?
YMAB Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q4 | -6.8 million USD | 26.5 million USD |
| 2025Q1 | -5.2 million USD | 20.9 million USD |
| 2025Q2 | -3.2 million USD | 19.5 million USD |
YMAB Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -96.3 million USD | 65.3 million USD |
| 2023 | -21.4 million USD | 84.8 million USD |
| 2024 | -29.7 million USD | 87.7 million USD |
YMAB
Price: $8.61
52 week price:
Earnings Per Share: -0.50 USD
P/E Ratio: -17.14
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 294900
Market Capitalization: 389.4 million